BBB Seminar: Ole Skøtt
Proteinuria and sodium retention: a novel mechanism
Main content
Ole Skøtt
Institute of Medical Biology, University of Southern Denmark, Odense, Denmark
Proteinuria and increased renal reabsorption of NaCl characterize the nephrotic syndrome. We have shown that protein-rich urine from nephrotic rats and from patients with nephrotic syndrome activate the epithelial sodium channel (ENaC) in cultured M-1 mouse collecting duct cells and in Xenopus laevis oocytes heterologously expressing ENaC. The activation depended on urinary serine protease activity. We identified plasmin as a urinary serine protease by matrix-assisted laser desorption/ionization time of-flight mass spectrometry. Purified plasmin activated ENaC currents, and inhibitors of plasmin abolished urinary protease activity and the ability to activate ENaC. In nephrotic syndrome, tubular urokinase-type plasminogen activator likely converts filtered plasminogen to plasmin. Consistent with this, the combined application of urokinase-type plasminogen activator and plasminogen stimulated amiloride-sensitive transepithelial sodium transport in M-1 cells and increased amiloride-sensitive whole-cell currents in Xenopus laevis oocytes heterologously expressing ENaC. Activation of ENaC by plasmin involved cleavage and release of an inhibitory peptide from the ENaC gamma subunit ectodomain. Cy3-labeled plasmin was found to bind to the surface of the mouse cortical collecting duct cell line, M-1. Binding depended on a GPI-anchored protein, and biotin-label transfer showed that the interaction partner was the GPI-anchored protein prostasin. Removal of GPI-anchored proteins from the M-1 cells with PI-PLC inhibited plasmin-stimulated ENaC current in monolayers of M-1 cells at low plasmin concentration, while at high plasmin concentrations, there was no difference between cell layers treated with or without PI-PLC. Knockdown of prostasin attenuated binding of plasmin to M1 cells and blocked plasmin-stimulated ENaC current in single M-1 cells as measured by whole-cell patch clamp. In M-1 cells expressing heterologous FLAG-tagged prostasin, gammaENaC and prostasin were co-localized. A monoclonal antibody directed against the inhibitory peptide of gammaENaC produced specific immunofluorescence labeling of M-1 cells. Pretreatment with plasmin abolished labeling of M-1 cells in a prostasin-dependent way. These data suggest that a defective glomerular filtration barrier allows passage of proteolytic enzymes, such that plasminogen is converted into plasmin in the tubule and it activates ENaC. At low concentrations, plasmin interacts with GPI-anchored prostasin, which leads to cleavage of the gamma-subunit and activation of ENaC, while at higher concentrations, plasmin directly activates ENaC.
Selected references:
Svenningsen et al. J Am Soc Nephrol. 2009, 20(2):299-310
Svenningsen et al. Am J Physiol Regul Integr Comp Physiol. 2009 [Epub ahead of print]
Host: Rolf Kåre Reed, Department of Biomedicine